Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Retinoin** is a Topix Pharmaceuticals physician-dispensed topical retinol skincare formulation and patented-brand delivery platform for age-defense skincare. Its patent-pending transdermal delivery system is intended to promote rapid skin retinization while reducing the irritation often associated with topical retinoids; Topix states that the formulation is coupled with bakuchiol, licorice root, and green tea polyphenols for age-defying and skin-soothing effects. The retinol component is expected to act after metabolic conversion to retinoic acid, activating retinoic acid receptor signaling involved in epidermal differentiation, keratinocyte turnover, and dermal collagen remodeling. ([topixpharm.com](https://topixpharm.com/science/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Retinoin.